TY - JOUR
T1 - Incidence, risk factors and perinatal outcomes for placenta accreta in Australia and New Zealand
T2 - A case-control study
AU - Farquhar, Cynthia M.
AU - Li, Zhuoyang
AU - Lensen, Sarah
AU - McLintock, Claire
AU - Pollock, Wendy
AU - Peek, Michael J.
AU - Ellwood, David
AU - Knight, Marian
AU - Homer, Caroline SE
AU - Vaughan, Geraldine
AU - Wang, Alex
AU - Sullivan, Elizabeth
N1 - Funding Information:
Acknowledgements We would like to acknowledge the support of participating maternity units and all AMOSS data collectors and coordinators in Australia and New Zealand. Contributors CF, MP, ES, CM, WP, DE, MK and CH conceptualised and designed the study protocol and case report forms. GV and ES managed data collection and oversaw operational aspects of the study. SL, ZL, ES and CF devised the data analysis. ZL, AW undertook the data analysis. CF, SL, ES and ZL led the drafting of the paper. All authors revised the manuscript and approved the final draft. Funding This work was supported by the National Health and Medical Research Council (App ID 510298) from 2008 to 2012 in Australia and the Perinatal and Maternal Mortality Review Committee in New Zealand. The funding sources had no involvement in the study design, conduct, analysis, manuscript drafting or decision to publish.
Publisher Copyright:
© Article author(s) 2017.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2017/10
Y1 - 2017/10
N2 - Objective Estimate the incidence of placenta accreta and describe risk factors, clinical practice and perinatal outcomes. Design Case-control study. Setting Sites in Australia and New Zealand with at least 50 births per year. Participants Cases were women giving birth (≥20 weeks or fetus ≥400 g) who were diagnosed with placenta accreta by antenatal imaging, at operation or by pathology specimens between 2010 and 2012. Controls were two births immediately prior to a case. A total of 295 cases were included and 570 controls. Methods Data were collected using the Australasian Maternity Outcomes Surveillance System. Primary and secondary outcome measures Incidence, risk factors (eg, prior caesarean section (CS), maternal age) and clinical outcomes of placenta accreta (eg CS, hysterectomy and death). Results The incidence of placenta accreta was 44.2/100 000 women giving birth (95% CI 39.4 to 49.5); however, this may overestimated due to the case definition used. In primiparous women, an increased odds of placenta accreta was observed in older women (adjusted OR (AOR) women≥40 vs <30: 19.1, 95% CI 4.6 to 80.3) and current multiple birth (AOR: 6.1, 95% CI 1.1 to 34.1). In multiparous women, independent risk factors were prior CS (AOR ≥2 prior sections vs 0: 13.8, 95% CI 7.4 to 26.1) and current placenta praevia (AOR: 36.3, 95% CI 14.0 to 93.7). There were two maternal deaths (case fatality rate 0.7%). Women with placenta accreta were more likely to have a caesarean section (AOR: 4.6, 95% CI 2.7 to 7.6) to be admitted to the intensive care unit (ICU)/high dependency unit (AOR: 46.1, 95% CI 22.3 to 95.4) and to have a hysterectomy (AOR: 209.0, 95% CI 19.9 to 875.0). Babies born to women with placenta accreta were more likely to be preterm, be admitted to neonatal ICU and require resuscitation.
AB - Objective Estimate the incidence of placenta accreta and describe risk factors, clinical practice and perinatal outcomes. Design Case-control study. Setting Sites in Australia and New Zealand with at least 50 births per year. Participants Cases were women giving birth (≥20 weeks or fetus ≥400 g) who were diagnosed with placenta accreta by antenatal imaging, at operation or by pathology specimens between 2010 and 2012. Controls were two births immediately prior to a case. A total of 295 cases were included and 570 controls. Methods Data were collected using the Australasian Maternity Outcomes Surveillance System. Primary and secondary outcome measures Incidence, risk factors (eg, prior caesarean section (CS), maternal age) and clinical outcomes of placenta accreta (eg CS, hysterectomy and death). Results The incidence of placenta accreta was 44.2/100 000 women giving birth (95% CI 39.4 to 49.5); however, this may overestimated due to the case definition used. In primiparous women, an increased odds of placenta accreta was observed in older women (adjusted OR (AOR) women≥40 vs <30: 19.1, 95% CI 4.6 to 80.3) and current multiple birth (AOR: 6.1, 95% CI 1.1 to 34.1). In multiparous women, independent risk factors were prior CS (AOR ≥2 prior sections vs 0: 13.8, 95% CI 7.4 to 26.1) and current placenta praevia (AOR: 36.3, 95% CI 14.0 to 93.7). There were two maternal deaths (case fatality rate 0.7%). Women with placenta accreta were more likely to have a caesarean section (AOR: 4.6, 95% CI 2.7 to 7.6) to be admitted to the intensive care unit (ICU)/high dependency unit (AOR: 46.1, 95% CI 22.3 to 95.4) and to have a hysterectomy (AOR: 209.0, 95% CI 19.9 to 875.0). Babies born to women with placenta accreta were more likely to be preterm, be admitted to neonatal ICU and require resuscitation.
KW - c-section
KW - caesarean
KW - placenta accreta
KW - placentation
UR - http://www.scopus.com/inward/record.url?scp=85031099344&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2017-017713
DO - 10.1136/bmjopen-2017-017713
M3 - Article
C2 - 28982832
AN - SCOPUS:85031099344
SN - 2044-6055
VL - 7
JO - BMJ Open
JF - BMJ Open
IS - 10
M1 - e017713
ER -